Drew D Kiraly
Overview
Explore the profile of Drew D Kiraly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farahbakhsh Z, Holleran K, Sens J, Fordahl S, Mauterer M, Lopez A, et al.
Nat Commun
. 2025 Feb;
16(1):1944.
PMID: 39994195
Alcohol use disorder is marked by disrupted behavioral and emotional states which persist into abstinence. The enduring synaptic alterations that remain despite the absence of alcohol are of interest for...
2.
Peck E, Holleran K, Curry A, Holter K, Estave P, Sens J, et al.
bioRxiv
. 2024 Aug;
PMID: 39211138
Synaptogyrin-3, a functionally obscure synaptic vesicle protein, interacts with vesicular monoamine and dopamine transporters, bringing together dopamine release and reuptake sites. Synaptogyrin-3 was reduced by chronic cocaine exposure in both...
3.
Lucerne K, Dean C, Osman A, Meckel K, Dave Y, Shipman A, et al.
Brain Behav Immun
. 2024 Aug;
122:137-149.
PMID: 39098439
Cocaine use disorder is a condition that leads to tremendous morbidity and mortality for which there are currently no FDA-approved pharmacotherapies. Previous research has demonstrated an important role for the...
4.
Thibeault K, Leonard M, Kondev V, Emerson S, Bethi R, Lopez A, et al.
Biol Psychiatry
. 2024 Jun;
97(6):590-601.
PMID: 38901723
Background: Substance use disorder is characterized by long-lasting changes in reward-related brain regions, such as the nucleus accumbens. Previous work has shown that cocaine exposure induces plasticity in broad, genetically...
5.
Farahbakhsh Z, Holleran K, Sens J, Fordahl S, Mauterer M, Lopez A, et al.
bioRxiv
. 2024 Apr;
PMID: 38559169
Alcohol use disorder is marked by disrupted behavioral and emotional states which persist into abstinence. The enduring synaptic alterations that remain despite the absence of alcohol are of interest for...
6.
Hofford R, Meckel K, Wiser E, Wang W, Sens J, Kim M, et al.
eNeuro
. 2024 Jan;
11(2).
PMID: 38164564
Opioid use disorder (OUD) is a public health crisis currently being exacerbated by increased rates of use and overdose of synthetic opioids, primarily fentanyl. Therefore, the identification of novel biomarkers...
7.
Osman A, Mervosh N, Strat A, Euston T, Zipursky G, Pollak R, et al.
Brain Behav Immun
. 2023 Sep;
114:311-324.
PMID: 37657643
Background: The pathophysiology of autism spectrum disorder (ASD) involves genetic and environmental factors. Mounting evidence demonstrates a role for the gut microbiome in ASD, with signaling via short-chain fatty acids...
8.
Hofford R, Kiraly D
Biol Psychiatry
. 2023 Aug;
95(4):329-338.
PMID: 37573004
Substance use disorders are a set of recalcitrant neuropsychiatric conditions that cause tremendous morbidity and mortality and are among the leading causes of loss of disability-adjusted life years worldwide. While...
9.
Meckel K, Simpson S, Godino A, Peck E, Sens J, Leonard M, et al.
Neuropsychopharmacology
. 2023 Aug;
49(2):386-395.
PMID: 37528220
Cocaine use disorder represents a public health crisis with no FDA-approved medications for its treatment. A growing body of research has detailed the important connections between the brain and the...
10.
Osman A, Hofford R, Meckel K, Dave Y, Zeldin S, Shipman A, et al.
Sci Rep
. 2023 Jul;
13(1):12223.
PMID: 37500710
Opioid Use Disorder (OUD) is associated with tremendous morbidity and mortality. Despite this burden, current pharmacotherapies for OUD are ineffective or intolerable for many patients. As such, interventions aimed at...